ATH 11.1% 0.4¢ alterity therapeutics limited

2.3 What happens if a listed entity ceases to meet one of the...

  1. 442 Posts.
    lightbulb Created with Sketch. 45
    2.3 What happens if a listed entity ceases to meet one of the eligibility
    criteria after it has obtained ordinary security holders’ approval?

    An approval under listing rule 7.1A lasts for 12 months from the date of
    the AGM, and does not lapse if the listed entity’s market capitalisation
    exceeds $300 million, or if it is included in the S&P/ASX 300 Index, at
    some time during that period. To seek another approval under listing
    rule 7.1A, the entity will need to meet both eligibility criteria at the date
    of its next AGM.


    I believe the current Placement approval was voted and approved on 28 November which means they still have another 8 months available for 3b issues.

    The run up overnight may have been more to do with snticipation of the forthcoming results than a sigh of relief that the company had "no choice" but to issue shares now on the basis of use-it or lose-it.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.4¢
Change
-0.001(11.1%)
Mkt cap ! $20.98M
Open High Low Value Volume
0.5¢ 0.5¢ 0.4¢ $14.55K 3.241M

Buyers (Bids)

No. Vol. Price($)
62 71906262 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 32338803 25
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.